ProDGNE Kick-Off Webinar
The ProDGNE Consortium is pleased to invite you to the ProDGNE Kick-Off webinar taking place on 3rd June at 6pm CEST.
ProDGNE is a 3 year transnational pre-clinical research project which aims to develop an innovative therapeutic compound to treat GNE Myopathy (GNEM), an ultra rare genetic muscle disease affecting young adults.
ProDGNE aims to ensure early patient partnership and represents a unique joint collaboration among patients, European and Canadian experts in clinical GNE Myopathy, sialic acid, organic synthesis, and -OMIC technologies.
The project is funded in the framework of the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call 2020 “Pre-Clinical Research to Develop Effective Therapies for Rare Diseases”.
For further information on ProDGNE please visit https://sites.fct.unl.pt/prodgne/ and follow ProDGNE on Twitter @ProDGNE